EZZ Life Science Holdings Limited reported earnings results for the half year ended December 31, 2022. For the half year, the company reported sales was AUD 15.13 million compared to AUD 6.21 million a year ago. Net income was AUD 1.3 million compared to AUD 0.0998 million a year ago.

Basic earnings per share from continuing operations was AUD 0.0304 compared to AUD 0.0024 a year ago. Diluted earnings per share from continuing operations was AUD 0.0304 compared to AUD 0.0024 a year ago.